Literature DB >> 9135961

Intake of a diet high in trans monounsaturated fatty acids or saturated fatty acids. Effects on postprandial insulinemia and glycemia in obese patients with NIDDM.

E Christiansen1, S Schnider, B Palmvig, E Tauber-Lassen, O Pedersen.   

Abstract

OBJECTIVE: High intake of trans fatty acids and saturated fatty acids (SFAs) is known to increase the risk of coronary heart disease. We studied the effects of diets enriched in various fatty acids on postprandial insulinemia and fasting serum levels of lipids and lipoproteins in obese patients with NIDDM. RESEARCH DESIGN AND METHODS: Sixteen obese NIDDM patients were studied in a free-living outpatient regimen. After a run-in period, the patients received three different isocaloric diets for 6 weeks using a randomized crossover design. The patients were instructed to keep the energy intake from carbohydrate and protein constant at 50 and 20 E% (percent of energy intake), respectively, on all three diets. The fat composition of the diets differed: saturated fat (SAT) diet (20 E% SFAs, 5 E% polyunsaturated fatty acids [PUFAs], and 5 E% monounsaturated fatty acids [MUFAs]) versus cis monounsaturated fatty acid (CMUFA) diet (20 E% cis-MUFAs, 5 E% PUFAs, and 5 E% SFAs) versus trans monounsaturated fatty acid (TMUFA) diet (20 E% trans-MUFAs, 5 E% PUFAs, and 5 E% SFAs). Fasting serum levels of lipids and lipoproteins were measured at baseline and in the fasting state before meal tolerance tests at the end of each study period. Insulin secretion was assessed from incremental serum insulin and C-peptide responses during the meal tests.
RESULTS: BMI, waist-to-hip ratio, and glycemic control remained stable throughout the study. After meal stimulation, postprandial glycemic responses were similar on all diets; however, serum insulin and C-peptide responses were greater following the TMUFA and SAT diets than following the baseline or CMUFA diets (P < 0.05). No statistical difference was found in fasting levels of serum lipids (total cholesterol, triglyceride, phospholipid, and nonesterified fatty acids) or lipoproteins of HDL cholesterol, VLDL cholesterol, LDL cholesterol, and apolipoprotein B between diets.
CONCLUSIONS: In the presence of unchanged glycemia, both dietary trans fatty acids and SFAs induce an increase in postprandial insulinemia in obese patients with NIDDM.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9135961     DOI: 10.2337/diacare.20.5.881

Source DB:  PubMed          Journal:  Diabetes Care        ISSN: 0149-5992            Impact factor:   19.112


  35 in total

Review 1.  The influence of dietary fat on insulin resistance.

Authors:  Jennifer C Lovejoy
Journal:  Curr Diab Rep       Date:  2002-10       Impact factor: 4.810

Review 2.  Diet, alcohol, and gout: how do we advise patients given recent developments?

Authors:  Hyon K Choi
Journal:  Curr Rheumatol Rep       Date:  2005-06       Impact factor: 4.592

3.  Characterization of human SCD2, an oligomeric desaturase with improved stability and enzyme activity by cross-linking in intact cells.

Authors:  Shaobo Zhang; Yanzhu Yang; Yuguang Shi
Journal:  Biochem J       Date:  2005-05-15       Impact factor: 3.857

Review 4.  Dietary interventions for metabolic syndrome: role of modifying dietary fats.

Authors:  Craig Lawrence Kien
Journal:  Curr Diab Rep       Date:  2009-02       Impact factor: 4.810

5.  Health benefits and evaluation of healthcare cost savings if oils rich in monounsaturated fatty acids were substituted for conventional dietary oils in the United States.

Authors:  Mohammad M H Abdullah; Stephanie Jew; Peter J H Jones
Journal:  Nutr Rev       Date:  2017-02-01       Impact factor: 7.110

6.  Replacements for trans fats-will there be an oil shortage?

Authors:  David C Klonoff
Journal:  J Diabetes Sci Technol       Date:  2007-05

7.  Detailed physiologic characterization reveals diverse mechanisms for novel genetic Loci regulating glucose and insulin metabolism in humans.

Authors:  Erik Ingelsson; Claudia Langenberg; Marie-France Hivert; Inga Prokopenko; Valeriya Lyssenko; Josée Dupuis; Reedik Mägi; Stephen Sharp; Anne U Jackson; Themistocles L Assimes; Peter Shrader; Joshua W Knowles; Björn Zethelius; Fahim A Abbasi; Richard N Bergman; Antje Bergmann; Christian Berne; Michael Boehnke; Lori L Bonnycastle; Stefan R Bornstein; Thomas A Buchanan; Suzannah J Bumpstead; Yvonne Böttcher; Peter Chines; Francis S Collins; Cyrus C Cooper; Elaine M Dennison; Michael R Erdos; Ele Ferrannini; Caroline S Fox; Jürgen Graessler; Ke Hao; Bo Isomaa; Karen A Jameson; Peter Kovacs; Johanna Kuusisto; Markku Laakso; Claes Ladenvall; Karen L Mohlke; Mario A Morken; Narisu Narisu; David M Nathan; Laura Pascoe; Felicity Payne; John R Petrie; Avan A Sayer; Peter E H Schwarz; Laura J Scott; Heather M Stringham; Michael Stumvoll; Amy J Swift; Ann-Christine Syvänen; Tiinamaija Tuomi; Jaakko Tuomilehto; Anke Tönjes; Timo T Valle; Gordon H Williams; Lars Lind; Inês Barroso; Thomas Quertermous; Mark Walker; Nicholas J Wareham; James B Meigs; Mark I McCarthy; Leif Groop; Richard M Watanabe; Jose C Florez
Journal:  Diabetes       Date:  2010-02-25       Impact factor: 9.461

Review 8.  Dietary fats and diabetes mellitus: is there a good fat?

Authors:  C J Segal-Isaacson; E Carello; J Wylie-Rosett
Journal:  Curr Diab Rep       Date:  2001-10       Impact factor: 4.810

Review 9.  Saturated fat, carbohydrate, and cardiovascular disease.

Authors:  Patty W Siri-Tarino; Qi Sun; Frank B Hu; Ronald M Krauss
Journal:  Am J Clin Nutr       Date:  2010-01-20       Impact factor: 7.045

Review 10.  A reappraisal of the impact of dairy foods and milk fat on cardiovascular disease risk.

Authors:  J Bruce German; Robert A Gibson; Ronald M Krauss; Paul Nestel; Benoît Lamarche; Wija A van Staveren; Jan M Steijns; Lisette C P G M de Groot; Adam L Lock; Frédéric Destaillats
Journal:  Eur J Nutr       Date:  2009-03-04       Impact factor: 5.614

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.